co
Corporate
Observer
Homepage
Data
Great Britain
Company
NORWICH PHARMA TECHNOLOGIES LIMITED

NORWICH PHARMA TECHNOLOGIES LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source

    • Overview

    Company NameNORWICH PHARMA TECHNOLOGIES LIMITED
    Company StatusDissolved
    Legal FormPrivate limited company
    Company Number 05872525
    JurisdictionEngland/Wales
    Date of Creation
    Date of Cessation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of NORWICH PHARMA TECHNOLOGIES LIMITED?

    • Activities of other holding companies n.e.c. (64209) / Financial and insurance activities

    Where is NORWICH PHARMA TECHNOLOGIES LIMITED located?

    Registered Office Address
    Unit 1-9
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Essex
    Undeliverable Registered Office AddressNo

    What are the latest accounts for NORWICH PHARMA TECHNOLOGIES LIMITED?

    Last Accounts
    Last Accounts Made Up ToJun 30, 2020

    What are the latest filings for NORWICH PHARMA TECHNOLOGIES LIMITED?

    Filings
    DateDescriptionDocumentType

    Final Gazette dissolved via voluntary strike-off

    		1 pagesGAZ2(A)

    First Gazette notice for voluntary strike-off

    		1 pagesGAZ1(A)

    Application to strike the company off the register

    		1 pagesDS01

    Confirmation statement made on Jul 12, 2021 with no updates

    		3 pagesCS01

    Accounts for a dormant company made up to Jun 30, 2020

    		7 pagesAA

    Confirmation statement made on Jul 12, 2020 with no updates

    		3 pagesCS01

    Director's details changed for Mr Edmund Dwyer O'keeffe on Jul 13, 2019

    		2 pagesCH01

    Statement of capital on Nov 27, 2019

    • Capital: GBP 1
    		5 pagesSH19

    legacy

    		1 pagesSH20

    legacy

    		1 pagesCAP-SS

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of reduction in issued share capital

    		RES06

    Total exemption full accounts made up to Jun 30, 2019

    		7 pagesAA

    Confirmation statement made on Jul 12, 2019 with no updates

    		3 pagesCS01

    Total exemption full accounts made up to Jun 30, 2018

    		7 pagesAA

    Previous accounting period extended from Dec 31, 2017 to Jun 30, 2018

    		1 pagesAA01

    Confirmation statement made on Jul 12, 2018 with no updates

    		3 pagesCS01

    Total exemption full accounts made up to Dec 31, 2016

    		6 pagesAA

    Confirmation statement made on Jul 11, 2017 with no updates

    		3 pagesCS01

    Confirmation statement made on Jul 11, 2016 with updates

    		5 pagesCS01

    Total exemption small company accounts made up to Dec 31, 2015

    		4 pagesAA

    Total exemption small company accounts made up to Dec 31, 2014

    		5 pagesAA

    Annual return made up to Jul 11, 2015 with full list of shareholders

    		5 pagesAR01
    Associated Filings
    CategoryDateDescriptionType
    capitalAug 06, 2015

    Statement of capital on Aug 06, 2015

    • Capital: GBP 30,100
    		SH01

    Annual return made up to Jul 11, 2014 with full list of shareholders

    		5 pagesAR01
    Associated Filings
    CategoryDateDescriptionType
    capitalJul 24, 2014

    Statement of capital on Jul 24, 2014

    • Capital: GBP 30,100
    		SH01

    Total exemption small company accounts made up to Dec 31, 2013

    		3 pagesAA

    Annual return made up to Jul 11, 2013 with full list of shareholders

    		5 pagesAR01
    Associated Filings
    CategoryDateDescriptionType
    capitalAug 06, 2013

    Statement of capital following an allotment of shares on Aug 06, 2013

    		SH01
    View All Filings

    Who are the officers of NORWICH PHARMA TECHNOLOGIES LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    O'KEEFFE, Edmund Dwyer
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Unit 1-9
    Essex
    England
    		Director
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Unit 1-9
    Essex
    England
    		EnglandIrish66741790003
    SANSOM, Steve
    Unit 1-9
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Essex
    		Director
    Unit 1-9
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Essex
    		EnglandEnglish119357400001
    ROSS, Calvin
    Wellingham Farm
    Great Fransham
    NR19 2JF Dereham
    Norfolk
    		Secretary
    Wellingham Farm
    Great Fransham
    NR19 2JF Dereham
    Norfolk
    		British109913310001
    ENERGIZE DIRECTOR LIMITED
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		Secretary
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		97704170001
    ENERGIZE SECRETARY LIMITED
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		Secretary
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		55224770002
    ROSS, Calvin
    Wellingham Farm
    Great Fransham
    NR19 2JF Dereham
    Norfolk
    		Director
    Wellingham Farm
    Great Fransham
    NR19 2JF Dereham
    Norfolk
    		British109913310001
    ENERGIZE DIRECTOR LIMITED
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		Director
    31 Buxton Road
    SK2 6LS Stockport
    Cheshire
    		97704170001
    View Detailed Information on Officers and People with Significant Control

    Who are the persons with significant control of NORWICH PHARMA TECHNOLOGIES LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Mr Edmund Dwyer O'Keeffe
    Unit 1-9
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Essex
    		Apr 06, 2016
    Unit 1-9
    The Maltings Industrial Estate
    CM0 7EH Southminster
    Essex
    		No
    Nationality: Irish
    Country of Residence: England
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    • The person has the right to exercise, or actually exercises, significant influence or control over the company.
    View Detailed Information on Persons with Significant Control

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0